Dr. Daniel A. Ebroon, MD

Dr. Ebroon practices at Lynn Eye Surgery Center in Thousand Oaks, California.

Dr. Ebroon's NPI, 1023050655, was assigned on June 11, 2006. Dr. Ebroon graduated from Feinberg School of Medicine in 1993. Dr. Ebroon holds California license G85742.

Dr. Ebroon's primary practice is Lynn Eye Surgery Center, at 2230 Lynn Rd, Thousand Oaks, CA 91360. The practice phone is (805) 495-0458.

Dr. Ebroon's primary practice is Lynn Eye Surgery Center in Thousand Oaks, California. Dmand AI also links Dr. Ebroon to 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ebroon practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Ebroon's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Ebroon is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Ebroon's licenses on file in 3 states: California, Illinois and New York.

Dmand AI lists conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma, shingles and vision problems among the conditions Dr. Ebroon treats.

CMS data shows 17,541 Medicare services from Dr. Ebroon across 26 procedure codes in 2024, for 1,135 Medicare patients. Medicare paid $620,415 for them.

CMS counts 1,135 Medicare patients who saw Dr. Ebroon in 2024. The largest group is 65 to 74, with 507 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ebroon's median patient age at 70, with 71% women.

In 2024, Dr. Ebroon wrote 911 Medicare Part D claims for 455 patients. 66% of them were for generic drugs. CMS names the drug for 849 of them, across 13 drugs with 11 or more claims each, at $197,410 in total drug cost. In 2023, CMS named 861 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Ebroon for performance year 2024, reported as part of a group. Dr. Ebroon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Ebroon. Dr. Ebroon's most frequent co-authors are Malena M. Amato, MD, Paul J. Bryar, MD and Michael Henry Goldbaum, MD.

CMS Open Payments shows 289 general payments to Dr. Ebroon from 25 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Allergan Inc. paid the most, $51,296.

Dmand AI lists 1 award for Dr. Ebroon.

Dr. Ebroon graduated from Feinberg School of Medicine in 1993. Dr. Ebroon is a member of AAO.

Dr. Ebroon is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.